Evotec expands CRISPR-based technology offering with licence from ERS genomics
by Laura Catalina on May 2, 2018 9:12:13 AM
Hamburg, Germany, 02 May 2018: Evotec AG (Frankfurt Stock Exchange: EVT, TecDAX, ISIN: DE0005664809) today announced that it has expanded its CRISPR service offering with the addition of a licence from ERS Genomics Limited. With this licence, Evotec gains access to the leading technology for gene ...
Topics: Corporate, crispr, genomics, technology Read More